Ji Fanpu, Li Zhengxiao, Xue Hongan, Liu Layang, Deng Hong
Department of Infectious Disease, Second Affiliated Hospital, College of Medicine, Xi'an Jiaotong University, Xi'an, China.
South Med J. 2011 Feb;104(2):140-2. doi: 10.1097/SMJ.0b013e318206f8e3.
Combination of pegylated interferon and ribavirin has been the standard program for hepatitis C virus (HCV) infection. Pulmonary complications, although uncommon, have been reported in association with the use of interferon, and pleural effusion is rare. We report the second case of pleural effusion and interstitial pneumonitis in a patient treated with pegylated interferon and ribavirin for chronic HCV infection. The respiratory symptoms of our patient continued to progress even though the treatment with pegylated interferon had been withdrawn, but the symptoms improved dramatically following treatment with steroids.
聚乙二醇干扰素和利巴韦林联合使用一直是丙型肝炎病毒(HCV)感染的标准治疗方案。肺部并发症虽不常见,但已有使用干扰素相关的报道,而胸腔积液较为罕见。我们报告了第二例在接受聚乙二醇干扰素和利巴韦林治疗慢性HCV感染的患者中出现胸腔积液和间质性肺炎的病例。尽管已停用聚乙二醇干扰素治疗,但我们患者的呼吸道症状仍持续进展,但在使用类固醇治疗后症状显著改善。